Literature DB >> 29393757

Outcomes of chronic subdural hematoma in patients with liver cirrhosis.

Ching-Chang Chen1, Shao-Wei Chen2, Po-Hsun Tu1, Yin-Cheng Huang1, Zhuo-Hao Liu1, Alvin Yi-Chou Wang1, Shih-Tseng Lee1, Tien-Hsing Chen3, Chi-Tung Cheng4, Shang-Yu Wang4, An-Hsun Chou5.   

Abstract

OBJECTIVE: Burr hole craniostomy is an effective and simple procedure for treating chronic subdural hematoma (CSDH). However, the surgical outcomes and recurrence of CSDH in patients with liver cirrhosis (LC) remain unknown.
METHODS: A nationwide population-based cohort study was retrospectively conducted using data from the Taiwan National Health Insurance Research Database. The study included 29,163 patients who underwent first-time craniostomy for CSDH removal between January 1, 2001, and December 31, 2013. In total, 1223 patients with LC and 2446 matched non-LC control patients were eligible for analysis. All-cause mortality, surgical complications, repeat craniostomy, extended craniotomy, and long-term medical costs were analyzed.
RESULTS: The in-hospital mortality rate (8.7% vs 3.1% for patients with LC and non-LC patients, respectively), frequency of hospital admission, length of ICU stay, number of blood transfusions, and medical expenditures of patients with LC who underwent craniostomy for CSDH were considerably higher than those of non-LC control patients. Patients with LC tended to require an extended craniotomy to remove subdural hematomas in the hospital or during long-term follow-up. The surgical outcome worsened with an increase in the severity of LC.
CONCLUSIONS: Even for simple procedures following minor head trauma, LC remains a serious comorbidity with a poor prognosis.

Entities:  

Keywords:  CCI = Charlson Comorbidity Index; CIC = catastrophic illness certificate; CSDH = chronic SDH; CTP = Child-Turcotte-Pugh; ICD-9-CM = International Classification of Diseases, 9th Revision, Clinical Modification; LC = liver cirrhosis; NHI = National Health Insurance; NHIRD = NHI Research Database; SDH = subdural hematoma; TBI = traumatic brain injury; burr hole; chronic subdural hematoma; craniostomy; liver cirrhosis; vascular disorders

Mesh:

Year:  2018        PMID: 29393757     DOI: 10.3171/2017.8.JNS171103

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Predictors of Mortality, Withdrawal of Life-Sustaining Measures, and Discharge Disposition in Octogenarians with Subdural Hematomas.

Authors:  Ahmed Kashkoush; Jordan C Petitt; Husayn Ladhani; Vanessa P Ho; Michael L Kelly
Journal:  World Neurosurg       Date:  2021-10-07       Impact factor: 2.104

2.  Non-invasive Liver Fibrosis Scores Are Associated With Recurrence of Postoperative Chronic Subdural Hematoma.

Authors:  Peng Zhang; Hua Wang; Han Bao; Ning Wang; Zhen Chen; Qi Tu; Xiao Lin; Yun Li; Zezheng Zheng; Yu Chen; Linhui Ruan; Qichuan Zhuge
Journal:  Front Neurol       Date:  2022-06-13       Impact factor: 4.086

3.  Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.

Authors:  Victor Chien-Chia Wu; Shao-Wei Chen; An-Hsun Chou; Pei-Chi Ting; Chih-Hsiang Chang; Michael Wu; Ming-Jer Hsieh; Chao-Yung Wang; Shang-Hung Chang; Ming-Shyan Lin; Kuo-Chun Hung; I-Chang Hsieh; Pao-Hsien Chu; Cheng-Shyong Wu; Yu-Sheng Lin
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

4.  Clinical Characteristics and Current Managements for Patients with Chronic Subdural Hematoma : A Retrospective Multicenter Pilot Study in the Republic of Korea.

Authors:  Hyuk-Jin Oh; Youngbeom Seo; Yoon-Hee Choo; Young Il Kim; Kyung Hwan Kim; Sae Min Kwon; Min Ho Lee; Kyuha Chong
Journal:  J Korean Neurosurg Soc       Date:  2021-11-04

5.  Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis: A nationwide cohort study.

Authors:  Victor Chien-Chia Wu; Shao-Wei Chen; An-Hsun Chou; Michael Wu; Pei-Chi Ting; Shang-Hung Chang; Chao-Yung Wang; Ming-Shyan Lin; Kuo-Chun Hung; I-Chang Hsieh; Pao-Hsien Chu; Cheng-Shyong Wu; Yu-Sheng Lin
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.